Narrative review / 2018
Evidence for fasting or calorie restriction around chemotherapy remains unproven in cancer patients and requires clinical validation.
This review evaluates the role of fasting, fasting-mimicking diets, and caloric restriction mimetics in cancer prevention and treatment, particularly around chemotherapy. The author notes that transferring findings from cellular and animal models to cancer patients is not yet established, and that caution is warranted due to the risk of malnutrition and sarcopenia. Currently, fasting around chemotherapy remains a promising intuition that lacks validation from evidence-based clinical data.
- Study type
- Narrative review
- Who was studied
- Cancer patients receiving chemotherapy
- What was measured
- Efficacy and risks (e.g., malnutrition and sarcopenia) of fasting around chemotherapy
THE PAPER
To fast, or not to fast before chemotherapy, that is the question.
Caccialanza R, Cereda E, De Lorenzo F, Farina G, Pedrazzoli P, AIOM-SINPE-FAVO Working Group. BMC Cancer, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.